Hallwang Clinic - Private Oncology Clinic,
Circulating-tumor-cell-DNA (ctDNA) as a new prognostic marker in stage II and stage III colorectal carcinoma? Ongoing studies…
LBA30_PR Analysis of circulating tumour DNA (ctDNA) from patients enrolled in the IDEA-FRANCE phase III trial: Prognostic and predictive value for adjuvant treatment duration
Overview of attention for article published in Annals of Oncology, October 2019
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
Good Attention Score compared to outputs of the same age (79th percentile)
-
Good Attention Score compared to outputs of the same age and source (74th percentile)
Readers on
- mendeley
- 61 Mendeley